R G Sturton
- Biochemistry top 2%
- Lipid metabolism and biosynthesis 5
- Eicosanoids and Hypertension Pharmacology 2
- Physiology top 10%
- Asthma and respiratory diseases 4
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders 4
-
- Diet, Metabolism, and Disease 5
-
- Liver Disease Diagnosis and Treatment 7
-
- Pharmacological Effects and Assays 3
-
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- David N. BrindleyP. Haydn PritchardPeter J. BarnesAndrew G. NicholsonAlexandre TrifilieffM BowleyVictoria J. BarrettAlison J. Ford
- Journals
- Biochemical Journal (5 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Current Medical Research and Opinion (1 paper)
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
R G Sturton
20 papers receiving 679 citations
Peers
Comparison fields: 5 of 74
- Biochemistry 214
- Physiology 298
- Clinical Biochemistry 68
- Endocrinology, Diabetes and Metabolism 114
- Pulmonary and Respiratory Medicine 204
Countries citing papers authored by R G Sturton
This map shows the geographic impact of R G Sturton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R G Sturton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R G Sturton more than expected).
Fields of papers citing papers by R G Sturton
This network shows the impact of papers produced by R G Sturton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R G Sturton. The network helps show where R G Sturton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R G Sturton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 29 | |
| 2 | 2012 | 97 | |
| 3 | 2010 | 13 | |
| 4 | 2009 | 26 | |
| 5 | 2007 | 88 | |
| 6 | 1992 | 9 | |
| 7 | 1984 | 1 | |
| 8 | 1981 | 31 | |
| 9 | 1981 | 15 | |
| 10 | 1980 | 38 | |
| 11 | 1979 | 58 | |
| 12 | 1979 | 11 | |
| 13 | 1979 | 30 | |
| 14 | A mechanism by which fenfluramine and benfluorex could inhibit the synthesis of triacylglycerols [proceedings]. | 1978 | 1 |
| 15 | 1978 | 53 | |
| 16 | 1978 | 45 | |
| 17 | 1978 | 19 | |
| 18 | 1977 | 38 | |
| 19 | 1977 | 60 | |
| 20 | 1977 | 13 |
About R G Sturton
R G Sturton is a scholar working on Biochemistry, Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Animal Science and Zoology and Physiology, having authored 21 papers that have together received 718 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Diet, Metabolism, and Disease (5 papers), Lipid metabolism and biosynthesis (5 papers), Metabolism and Genetic Disorders (4 papers), Asthma and respiratory diseases (4 papers), Pharmacological Effects and Assays (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). The work is most often cited by research in Biochemistry (214 citations), Physiology (298 citations), Clinical Biochemistry (68 citations), Endocrinology, Diabetes and Metabolism (114 citations) and Pulmonary and Respiratory Medicine (204 citations). R G Sturton has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include David N. Brindley, P. Haydn Pritchard, Peter J. Barnes, Andrew G. Nicholson, Alexandre Trifilieff, M Bowley, Victoria J. Barrett, Alison J. Ford, Amanda Emmons and Valerie S. Morrison. Their work appears in journals such as Biochemical Journal, Journal of Pharmacology and Experimental Therapeutics, Current Medical Research and Opinion, Prostaglandins and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.